BACKGROUND: Multiple Sclerosis (MS) patients lacking CSF oligoclonal bands are
purported to have a milder course of disease. We reviewed the natural history of oligoclonal …

Background: Intrathecal oligoclonal band synthesis occurs in 95% of patients with clinically
definite MS but may also occur in the context of CNS infection and other inflammatory …

Background: The use of oligoclonal bands (OCBs) and cerebrospinal fluid (CSF) parameters
are established in the diagnosis of MS, but poorly as markers of disease. Objective: To …

Background and purpose Cerebrospinal fluid (CSF) neurofilament light protein (NFL) is a
promising biomarker of axonal injury and neurodegeneration. Here CSF lymphocyte …

Objective We investigated the correlation of anti-myelin oligodendrocyte glycoprotein-(anti-
MOG) and anti-myelin basic protein antibodies (anti-MBP) in serum of CIS patients with …

Examination of cerebrospinal fluid (CSF) in the context of multiple sclerosis (MS), is valuable
for several reasons. First, routine diagnostic evaluation of CSF cell counts and various forms …

There is an evident need for a quantitative laboratory marker for ascertaining disease activity
and treatment effects in multiple sclerosis (MS) patients. Activity of the disease process in …

To assess the role of CSF oligoclonal bands (OB) in determining the clinical outcome in
patients with relapsing-remitting multiple sclerosis (RRMS) treated with IFN-β, we carried out …

Cerebrospinal fluid (CSF) samples from 150 patients with multiple sclerosis (MS) and 190
patients with other neurological disorders were examined with a battery of tests (the IgG …

In the multicenter, randomized, placebo‐controlled trial of alternate‐day injections of
recombinant interferon beta‐1b in relapsing‐remitting multiple sclerosis (MS), urine …